Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdou Amza

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
The American Journal of Tropical Medicine and Hygiene|January 5, 2019
Mass Azithromycin Distribution to Prevent Childhood Mortality: A Pooled Analysis of Cluster-Randomized TrialsCatherine E Oldenburg, Ahmed M Arzika, Abdou Amza, et al.
Plos Neglected Tropical Diseases|December 9, 2024
Seroepidemiology of trachoma in a low prevalence region receiving annual mass azithromycin distribution in Maradi, NigerAbdou Amza, Boubacar Kadri, Beido Nassirou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2024
Assessment of Spillover of Antimicrobial Resistance to Untreated Children 7-12 Years Old After Mass Drug Administration of Azithromycin for Child Survival in Niger: A Secondary Analysis of the MORDOR Cluster-Randomized TrialBrittany Peterson, Ahmed M Arzika, Abdou Amza, et al.
Plos Neglected Tropical Diseases|May 1, 2012
Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trialAbdou Amza, Boubacar Kadri, Baido Nassirou, et al.
Malaria Journal|December 5, 2019
Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trialCatherine E Oldenburg, Abdou Amza, Gretchen Cooley, et al.
The American Journal of Tropical Medicine and Hygiene|March 12, 2014
Impact of mass azithromycin distribution on malaria parasitemia during the low-transmission season in Niger: a cluster-randomized trialBruce D Gaynor, Abdou Amza, Boubacar Kadri, et al.
Plos Neglected Tropical Diseases|January 29, 2019
Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic NigerJessica S Kim, Catherine E Oldenburg, Gretchen Cooley, et al.
PLOS Global Public Health|November 15, 2023
Comparison of door-to-door and fixed-point delivery of azithromycin distribution for child survival in Niger: A cluster-randomized trialAhmed M Arzika, Ramatou Maliki, Abdou Amza, et al.
Trials|February 19, 2026
Azithromycin mass drug administration to reduce child mortality in Niger (AVENIR II): a master protocol for a cluster-randomized adaptive platform trial to evaluate community-based health interventionsAhmed M Arzika, Abdou Amza, Sani Ousmane, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
Azithromycin mass drug administration to reduce child mortality in Niger (AVENIR II): a master protocol for a cluster-randomized adaptive platform trial to evaluate community-based health interventionsAhmed M Arzika, Abdou Amza, Sani Ousmane, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
The American Journal of Tropical Medicine and Hygiene|January 5, 2019
Mass Azithromycin Distribution to Prevent Childhood Mortality: A Pooled Analysis of Cluster-Randomized TrialsCatherine E Oldenburg, Ahmed M Arzika, Abdou Amza, et al.
Plos Neglected Tropical Diseases|December 9, 2024
Seroepidemiology of trachoma in a low prevalence region receiving annual mass azithromycin distribution in Maradi, NigerAbdou Amza, Boubacar Kadri, Beido Nassirou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2024
Assessment of Spillover of Antimicrobial Resistance to Untreated Children 7-12 Years Old After Mass Drug Administration of Azithromycin for Child Survival in Niger: A Secondary Analysis of the MORDOR Cluster-Randomized TrialBrittany Peterson, Ahmed M Arzika, Abdou Amza, et al.
Plos Neglected Tropical Diseases|May 1, 2012
Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trialAbdou Amza, Boubacar Kadri, Baido Nassirou, et al.
Malaria Journal|December 5, 2019
Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trialCatherine E Oldenburg, Abdou Amza, Gretchen Cooley, et al.
The American Journal of Tropical Medicine and Hygiene|March 12, 2014
Impact of mass azithromycin distribution on malaria parasitemia during the low-transmission season in Niger: a cluster-randomized trialBruce D Gaynor, Abdou Amza, Boubacar Kadri, et al.
Plos Neglected Tropical Diseases|January 29, 2019
Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic NigerJessica S Kim, Catherine E Oldenburg, Gretchen Cooley, et al.
PLOS Global Public Health|November 15, 2023
Comparison of door-to-door and fixed-point delivery of azithromycin distribution for child survival in Niger: A cluster-randomized trialAhmed M Arzika, Ramatou Maliki, Abdou Amza, et al.
Trials|February 19, 2026
Azithromycin mass drug administration to reduce child mortality in Niger (AVENIR II): a master protocol for a cluster-randomized adaptive platform trial to evaluate community-based health interventionsAhmed M Arzika, Abdou Amza, Sani Ousmane, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
Azithromycin mass drug administration to reduce child mortality in Niger (AVENIR II): a master protocol for a cluster-randomized adaptive platform trial to evaluate community-based health interventionsAhmed M Arzika, Abdou Amza, Sani Ousmane, et al.
Pageof 7